Swiss National Bank Sells 102,400 Shares of Corteva, Inc. $CTVA

Swiss National Bank decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 4.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,966,383 shares of the company’s stock after selling 102,400 shares during the quarter. Swiss National Bank’s holdings in Corteva were worth $132,986,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CTVA. Brighton Jones LLC lifted its position in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after acquiring an additional 11,760 shares during the period. Woodline Partners LP lifted its position in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the period. Savant Capital LLC increased its holdings in Corteva by 20.7% in the 2nd quarter. Savant Capital LLC now owns 20,711 shares of the company’s stock valued at $1,544,000 after buying an additional 3,548 shares during the period. Wedbush Securities Inc. lifted its holdings in shares of Corteva by 11.7% during the 2nd quarter. Wedbush Securities Inc. now owns 5,253 shares of the company’s stock worth $391,000 after acquiring an additional 549 shares during the period. Finally, Fox Run Management L.L.C. bought a new position in Corteva in the second quarter valued at approximately $238,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Down 2.6%

CTVA opened at $76.30 on Wednesday. The company has a market cap of $51.31 billion, a P/E ratio of 48.29, a price-to-earnings-growth ratio of 2.68 and a beta of 0.72. The company has a fifty day moving average price of $73.40 and a two-hundred day moving average price of $69.06. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same period in the previous year, the company posted $0.32 EPS. The firm’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Analysts Set New Price Targets

A number of research firms have issued reports on CTVA. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Wolfe Research lifted their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. JPMorgan Chase & Co. lowered Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 target price on shares of Corteva in a research report on Thursday, February 5th. Finally, Bank of America upped their price objective on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average price target of $82.90.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.15% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.